Prioritizing future research on off-label prescribing: results of a quantitative evaluation
about
Patient-reported outcomes as a source of evidence in off-label prescribing: analysis of data from PatientsLikeMeConcerns about quetiapineConflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosuresPharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012Changes in glitazone use among office-based physicians in the U.S., 2003-2009.Impact of FDA black box advisory on antipsychotic medication useUnsupported off-label chemotherapy in metastatic colon cancer.Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.Potential underuse, overuse, and inappropriate use of antidepressants in older veteran nursing home residents.An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.Determining the reasons for medication prescriptions in the EHR using knowledge and natural language processingAnalyzing patterns of drug use in clinical notes for patient safetyPersonalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.Off-licence prescribing and regulation in psychiatry: current challenges require a new model of governance.Adverse reactions to duloxetine in depression.Off-label use of drugs and medical devices: a review of policy implications.Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.Off-label and unlicensed utilisation of medicines in a French paediatric hospital.Concerns about quetiapine.Off-label use of rituximab in a multipayer insurance system.Community child psychiatric medication experiences measured by an internet-based, prospective parent survey of retail pharmacy customers.Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.Montelukast use-a 19-year nationwide drug utilisation study.[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].Patterns and predictors of off-label prescription of psychiatric drugsOff-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctorsAn evidence-based systematic review of the off-label uses of lisinopril
P2860
Q24595345-1A60F5F9-408A-4CBF-84AF-48B5B59B18A5Q26773288-83765C8C-E234-4884-B175-D8B3D8F7CFAAQ28482115-26250764-D68B-40A9-85E6-D9696F3740C6Q28552890-BF31902C-8924-4675-B611-60531793202EQ33751542-9C4772C8-49FF-440E-B5DD-17572051FD3AQ34092198-F34B2CBC-D8FD-4343-9CF5-637F01D86412Q34526503-8B24AAED-00D9-49F4-B4B2-1C26F2CDF4F3Q34680866-1AF9201F-7D87-472B-87DF-D00CBB805604Q35171130-C13FF1F4-2261-4E1F-99F1-798216AD8305Q35545776-C794F539-2FA2-433A-8A84-BBD38DE2AE77Q35625305-9FACFF6F-70B7-4385-8168-E2ACB13A4721Q36082925-17DB47EF-F5CE-4B3F-AD60-462593C76C33Q36136786-E9C3BE5F-538E-42E2-99DB-76CD849B7E87Q36678132-4FA0FE91-DE5A-42E6-9653-0B11A23C867FQ37248061-BB19B0B7-6D44-47E3-B8CD-7832C53032F5Q37872294-C5C0F279-2229-4378-ACD8-D2DA5E43032DQ37999651-D8CC6E3C-B044-42D2-9E1D-74566AEE5C18Q38652321-E485734B-08EB-4920-B257-AA22BD0FCFD7Q40513913-4AC995A4-7B99-4B14-AE02-6C8D96F38C7AQ41965125-4A9D1400-E0D9-4CB4-BC33-BAAF8A3EC34DQ42665938-609EB0C2-339B-4E1B-A2FB-2C11ABAC2AEEQ45978938-49CE2C50-3CD4-4F2F-89E1-C0F18CF511D7Q47421577-3D1D1ECB-0FFF-463F-8EED-B27A50B01F5BQ47854982-59F59413-6047-47C8-82F5-7AE9EAF661A6Q52889440-94CD4193-6F8B-4C10-8152-88AD615450F1Q56395428-ADCBAEEC-9D17-4B86-8DF4-12B0CDEE7524Q57359747-A5593C8B-565E-485D-A753-29D4BEB76D25Q57487671-7C64F414-E4B3-4C0C-A551-EBB3D687EB94
P2860
Prioritizing future research on off-label prescribing: results of a quantitative evaluation
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Prioritizing future research o ...... s of a quantitative evaluation
@ast
Prioritizing future research o ...... s of a quantitative evaluation
@en
type
label
Prioritizing future research o ...... s of a quantitative evaluation
@ast
Prioritizing future research o ...... s of a quantitative evaluation
@en
prefLabel
Prioritizing future research o ...... s of a quantitative evaluation
@ast
Prioritizing future research o ...... s of a quantitative evaluation
@en
P2093
P2860
P356
P1433
P1476
Prioritizing future research o ...... s of a quantitative evaluation
@en
P2093
David Meltzer
G Caleb Alexander
Glen T Schumock
Ky-Van Lee
Randall S Stafford
Surrey M Walton
P2860
P304
P356
10.1592/PHCO.28.12.1443
P407
P577
2008-12-01T00:00:00Z